| 注册
首页|期刊导航|转化医学杂志|膀胱出口梗阻诱导膀胱纤维化分子机制及治疗策略研究进展

膀胱出口梗阻诱导膀胱纤维化分子机制及治疗策略研究进展

汪松 陈林 何江枢 李嘉 龙军 杨进 梁国标 吴金邦 吴波

转化医学杂志2023,Vol.12Issue(6):386-395,10.
转化医学杂志2023,Vol.12Issue(6):386-395,10.DOI:10.3969/j.issn.2095-3097.2023.06.016

膀胱出口梗阻诱导膀胱纤维化分子机制及治疗策略研究进展

Research Progress on Molecular Mechanisms and Treatment Strategies of Bladder Outlet Obstruction Induced Bladder Fibrosis

汪松 1陈林 1何江枢 1李嘉 1龙军 1杨进 2梁国标 3吴金邦 4吴波5

作者信息

  • 1. 563000 贵州 遵义,遵义医科大学||610081 成都,成都大学附属医院泌尿外科
  • 2. 610081 成都,成都大学附属医院泌尿外科
  • 3. 563000 贵州 遵义,遵义医科大学
  • 4. 618000 四川 德阳,德阳第五医院泌尿外科
  • 5. 610036 成都,成都市郫都区人民医院泌尿外科
  • 折叠

摘要

Abstract

Bladder outlet obstruction(BOO)-induced bladder fibrosis can lead to irreversible functional and structural changes in the bladder,which is the end-stage change of bladder remodeling and seriously affects the quality of life of pa-tients.Mechanical stress,ischemia hypoxia,and inflammatory infiltration are important factors that initiate bladder fibrosis under long-term obstruction.On the one hand,they promote the production of extracellular matrix and collagen,while on the other hand,they inhibit their degradation and deposit a large amount on the bladder wall,resulting in a decrease in bladder wall compliance,capacity,and contraction force.At present,significant progress has been made in drug research to prevent bladder fibrosis and improve bladder function,including clinical drugs,natural Chinese herbal ingredients,polymer materials,and stem cell therapy.This review mainly summarizes the molecular mechanisms and therapeutic strategies of BOO-induced bladder fibrosis,providing certain ideas and directions for subsequent research,and also providing a theoretical basis for the development and use of related drugs.

关键词

膀胱出口梗阻/膀胱疾病/纤维化/分子机制/治疗/细胞外基质/胶原/综述

Key words

Bladder outlet obstruction/Bladder disease/Fibrosis/Molecular mechanism/Treatment/Extracellular matrix/Collagen/Review

分类

医药卫生

引用本文复制引用

汪松,陈林,何江枢,李嘉,龙军,杨进,梁国标,吴金邦,吴波..膀胱出口梗阻诱导膀胱纤维化分子机制及治疗策略研究进展[J].转化医学杂志,2023,12(6):386-395,10.

基金项目

国家自然科学基金(81500577) (81500577)

四川省科技厅自然科学基金项目(2022NSFSC1592) (2022NSFSC1592)

四川省医学科研课题(S19017、S17002、Q20013、Q19022) (S19017、S17002、Q20013、Q19022)

成都大学临床医学院附属医院创新团队项目(CDFYCX202207) (CDFYCX202207)

成都市科技局重点研发支撑计划(2022YF0501441SN) (2022YF0501441SN)

转化医学杂志

OACSTPCD

2095-3097

访问量0
|
下载量0
段落导航相关论文